Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01224444
Other study ID # DMS-21237
Secondary ID
Status Completed
Phase N/A
First received October 19, 2010
Last updated December 30, 2014
Start date May 2008
Est. completion date January 2013

Study information

Verified date December 2014
Source White River Junction VAMC
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

Colorectal cancer is the second most common cause of cancer death in the US. Colonoscopy is considered the best test colorectal cancer screening. It allows resection of adenomatous polyps (a known cancer precursor) and thus, interrupt the adenoma-carcinoma sequence. Despite the potential benefit of screening colonoscopy recent studies have reported cases of colorectal cancers in a short interval after prior screening or surveillance colonoscopies. One possible cause of such interval cancers may be incomplete resection of adenomatous polyps and hence ongoing growth and cancer development in such lesions. Complete resection may be particularly important for polyps of at least 5mm in size as up 10% of such polyps higher risk lesions as villous adenoma, tubulovillous adenoma, high grade dysplasia, or early carcinoma.

Although adenoma resection of sessile and flat adenomatous polyps between 5 and 20mm is believed to be well standardized data on complete resection of adenomatous tissue are sparse. This may be related to the assumption that using a snare with electro-cautery will successfully remove the polyp and cauterize remaining marginal adenomatous tissue and hence completely remove and or destroy the lesion.

The investigators are interested in examining how often sessile adenomatous polyps between 5 and 20mm are completely removed using standard polypectomy snare. The investigation was also directed at a comparison between complete resection of polyps between 5 and 9mm and 10 and 20mm.


Description:

All patients who present for a colonoscopy and meet inclusion and exclusion criteria will be asked to participate, and all patients with resectable polyps will be included. See also inclusion and exclusion criteria.

All patients will have undergone a regular bowel preparation with polyethylene glycol lavage with 4-6 L until clear rectal fluid is evacuated.

Polyp resection will be performed by experienced endoscopists (each with over 500 colonoscopies performed). All polyps between 5 and 20mm will be removed with an electro-cautery snare. Polyp size will be estimated using the snare catheter (2.5mm) or the snare diameter (10x20mm, 15x30mm, 20x20mm) before resection. The endoscopist will grade the difficulty of resection. Following the resection, the endoscopist will closely examine the resection margins. Biopsies will be taken from resection margins: 2 biopsies will be obtained from opposite margins for polyps 5-9mm, and 4 biopsies will be taken for polyps 10-20mm from all four quadrants of the resection margins. In case of assumed incomplete resection this will be documented and further (piecemeal) resections should be done, if this is not feasible, margins can be cauterized according to standard polypectomy resection (e.g. by argon beamer coagulation) after previous biopsy. Only those polyps that are found to be adenomatous polyps will be included in the analysis.

If polyp resection is complicated by bleeding (not self-sustained), no biopsies will be taken and any additional polyps that will be found during the remaining examination will be excluded from analysis. Any bleeding from the margins after polypectomy will be treated by endoscopic injection using diluted epinephrine (1:10.000).

A single research subject may have many eligible polyps. To avoid taking many biopsies, the investigators will not include more than 5 eligible polyps (the first 5 that are detected) per patient in the study.

Laboratory Analysis:

Polyps and biopsies will be sent to the pathology lab of each center. The polyps will be evaluated according to common practice. In addition information regarding resection margins will be provided for each polyp: R0= free of adenomatous tissue, R1=adenomatous tissue detected in the margin. This information is not routinely provided by the pathologist as there is so far no data whether this information is reliable. Only adenomatous polyps will be included in the analysis. Hyperplastic polyps will not be included. Biopsies will only be processed after the diagnosis of an adenomatous polyp was made. Biopsies will be evaluated for presence of adenomatous tissue. The additional impact for the pathology lab includes a) processing of biopsies belonging to the polyp specimens, and b) providing information on polyp margins. The VA pathology lab estimated the financial impact to be low and there will be no financial requests. The pathological diagnosis, including the reading of the biopsies, will become part of the medical record. If biopsies contain adenomatous tissue the patient will be ask to return for a follow-up colonoscopy within 1 year. This is within current standard of care to repeat a colonoscopy to assure complete adenoma resection.


Recruitment information / eligibility

Status Completed
Enrollment 269
Est. completion date January 2013
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 85 Years
Eligibility Inclusion Criteria:

- Any patient =40 and <85 who presents for a colonoscopy and does not meet any of the exclusion criteria mentioned below will be asked to participate

- All patients who are found to have colonic polyp between 5 and 20mm in size will be included in the study

Exclusion Criteria:

- Pedunculated polyps (estimated stalk diameter < 50% polyp head diameter, stalk at least 5 mm)

- Any suspicion of perforation or deeper defects after polypectomy, irrespective whether treated or not.

- Post-polypectomy bleeding requiring hemostasis.

- Patients with known inflammatory bowel disease or active colitis

- Patients who are receiving an emergency colonoscopy

- Poor general health (ASA class>3)

- Patients on coumadin or with coagulopathy with an elevated INR =1.8, or platelets <50.

- Poor bowel preparation

- Patients who do not consent

- Pregnancy

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
standard polypectomy snare
Electrocautery snare resection of sessile colonic polyps

Locations

Country Name City State
United States Dartmouth Hitchcock Medical Center Lebanon New Hampshire
United States White River Junction VAMC White River Junction Vermont

Sponsors (2)

Lead Sponsor Collaborator
White River Junction VAMC Dartmouth-Hitchcock Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent of Incompletely Resected Adenomatous Polyps Proportion of incompletely resected adenomatous polyps (5 to 20mm), defined by remaining adenomatous tissue in marginal biopsies after snare resection. 1 year No
Secondary Incomplete Adenoma Resection of Small and Large Adenomas Comparison of the proportion of incompletely resected adenomatous polyps by size (5-9mm versus 10-20mm). 1 year No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05954949 - Detection of Ileoanal Pouch/Reservoir Adenomas
Completed NCT03647176 - A Comparison of the Resection Rate of Cold Snare Polypectomy for Large (10-15 mm) and Small (5-9 mm) Colorectal Polyps N/A
Not yet recruiting NCT01214031 - Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy N/A
Completed NCT04287335 - Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
Completed NCT00432913 - Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa Phase 2/Phase 3
Completed NCT04195646 - Computer Aided Detection of Polyps During Colonoscopy Procedures N/A
Terminated NCT01476631 - Step Down Colon Cancer Risk N/A
Recruiting NCT02263144 - Resect and Discard Extension to FICE of NIcE Classification N/A
Completed NCT05875584 - Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection
Completed NCT01638091 - Practice-Based Learning to Predict Polyp Histology at Colonoscopy N/A
Terminated NCT00865527 - Pilot Study of Colon Cancer Screening Tests N/A
Withdrawn NCT04964596 - Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic N/A
Terminated NCT00486512 - Chemoprevention of Colorectal Adenomas Phase 3
Completed NCT03197987 - Comparison of Two Devices During Colonoscopy N/A
Terminated NCT03220711 - Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon N/A
Completed NCT00966420 - Traction Assisted Polypectomy of the Intestine N/A
Terminated NCT00118989 - Curcumin for the Chemoprevention of Colorectal Cancer N/A
Recruiting NCT06220617 - Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
Completed NCT02476682 - Non-invasive Risk Stratification of CR AMN/SSP
Completed NCT02374515 - Safety and Efficacy of Endocuff-assisted Colonoscopy for Adenoma Detection. N/A